FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

387237004: Dextromethorphan hydrobromide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461415018 Dextromethorphan hydrobromide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481340017 Dextromethorphan hydrobromide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1491947010 Dextromethmorphan hydrobromide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4498701000005110 Dextromethorphanhydrobromid da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dextromethorphan hydrobromide (substance) Is a Dextromethorphan (substance) false Inferred relationship Some
Dextromethorphan hydrobromide (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. N-methyl-D-aspartate receptor antagonist (disposition) true Inferred relationship Some
Dextromethorphan hydrobromide (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Opioid receptor agonist (disposition) false Inferred relationship Some
Dextromethorphan hydrobromide (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Sigma-1 receptor agonist (disposition) true Inferred relationship Some
Dextromethorphan hydrobromide (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Dextromethorphan (substance) true Inferred relationship Some
Dextromethorphan hydrobromide (substance) Is a ether false Inferred relationship Some
Dextromethorphan hydrobromide (substance) Is a Substance with sigma-1 receptor agonist mechanism of action (substance) true Inferred relationship Some
Dextromethorphan hydrobromide (substance) Is a NMDA receptor antagonist true Inferred relationship Some
Dextromethorphan hydrobromide (substance) Is a Substance with ether structure true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Accidental dextromethorphan poisoning Causative agent False Dextromethorphan hydrobromide (substance) Inferred relationship Some
Intentional dextromethorphan poisoning Causative agent False Dextromethorphan hydrobromide (substance) Inferred relationship Some
Forgiftning med dextrometorfan, uvist med hvilken hensigt Causative agent False Dextromethorphan hydrobromide (substance) Inferred relationship Some
allergi over for dextromethorphanhydrobromid Causative agent False Dextromethorphan hydrobromide (substance) Inferred relationship Some
carbinoxaminmaleat 4 mg/5 ml + dextromethorphanhydrobromid 15 mg/5 ml + pseudoephedrinhydrochlorid 60 mg/5 ml syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 2 mg/1 ml/4 mg/1 ml/25 mg/1 ml væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
carbinoxaminmaleat 2 mg/1 ml + dextromethorphanhydrobromid 4 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
brompheniraminmaleat + dextromethorphanhydrobromid + phenylpropanolaminhydrochlorid 2 mg/5 ml 10 mg/5 ml 12,5 mg/5 ml syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 2 mg/5 ml 10 mg/5 ml 30 mg/5 ml syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml 15 mg/5 ml 60 mg/5 ml syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
brompheniraminmaleat 2 mg + dextromethorphanhydrobromid 10 mg + phenylpropanolaminhydrochlorid 12,5 mg væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
dextromethorphanhydrobromid 15 mg + promethazinhydrochlorid 6,25 mg væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml 15 mg/5 ml 45 mg/5 ml syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
brompheniraminmaleat 4 mg/5 ml + dextromethorphanhydrobromid 30 mg/5 ml + pseudoephedrinhydrochlorid 60 mg/5 ml syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml/12,5 mg/5 ml/60 mg/5 ml syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 1 mg/1 ml/4 mg/1 ml/15 mg/1 ml dråber The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
dextromethorphanhydrobromid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
Poisoning by dextromethorphan Causative agent False Dextromethorphan hydrobromide (substance) Inferred relationship Some
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
dextromethorphanhydrobromid 6,67 mg/5 ml syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
dextromethorphan 7,5 mg pastil The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
dextromethorphanhydrobromid + promethazinhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
dextromethorphanhydrobromid 7,5 mg/5 ml eliksir til oral anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
dextromethorphanhydrobromid 7,5 mg/5 ml syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
brompheniraminmaleat + dextromethorphanhydrobromid + phenylpropanolaminhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextromethorphan hydrobromide (substance) Inferred relationship Some
Accidental dextromethorphan poisoning Causative agent False Dextromethorphan hydrobromide (substance) Inferred relationship Some
Intentional dextromethorphan poisoning Causative agent False Dextromethorphan hydrobromide (substance) Inferred relationship Some
allergi over for dextromethorphanhydrobromid Causative agent False Dextromethorphan hydrobromide (substance) Inferred relationship Some 1
allergi over for dextromethorphanhydrobromid Causative agent False Dextromethorphan hydrobromide (substance) Inferred relationship Some 2
Dextromethorphan hydrobromide monohydrate (substance) Is a False Dextromethorphan hydrobromide (substance) Inferred relationship Some
Dextromethorphan hydrobromide monohydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Dextromethorphan hydrobromide (substance) Inferred relationship Some
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextromethorphan hydrobromide (substance) Inferred relationship Some 3
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextromethorphan hydrobromide (substance) Inferred relationship Some 3
Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextromethorphan hydrobromide (substance) Inferred relationship Some 2
Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextromethorphan hydrobromide (substance) Inferred relationship Some 2
Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextromethorphan hydrobromide (substance) Inferred relationship Some 3
Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextromethorphan hydrobromide (substance) Inferred relationship Some 3
Product containing precisely dextromethorphan hydrobromide 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextromethorphan hydrobromide (substance) Inferred relationship Some 1
Product containing precisely dextromethorphan hydrobromide 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextromethorphan hydrobromide (substance) Inferred relationship Some 1
Dextromethorphan hydrobromide 1.33 mg/mL oral solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextromethorphan hydrobromide (substance) Inferred relationship Some 1
Dextromethorphan hydrobromide 1.33 mg/mL oral solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextromethorphan hydrobromide (substance) Inferred relationship Some 1
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextromethorphan hydrobromide (substance) Inferred relationship Some 1
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextromethorphan hydrobromide (substance) Inferred relationship Some 1
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextromethorphan hydrobromide (substance) Inferred relationship Some 3
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextromethorphan hydrobromide (substance) Inferred relationship Some 3
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextromethorphan hydrobromide (substance) Inferred relationship Some 1
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextromethorphan hydrobromide (substance) Inferred relationship Some 1
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextromethorphan hydrobromide (substance) Inferred relationship Some 2
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextromethorphan hydrobromide (substance) Inferred relationship Some 2
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextromethorphan hydrobromide (substance) Inferred relationship Some 3
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextromethorphan hydrobromide (substance) Inferred relationship Some 3
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextromethorphan hydrobromide (substance) Inferred relationship Some 3
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextromethorphan hydrobromide (substance) Inferred relationship Some 3
Dextromethorphan hydrobromide anhydrous This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Dextromethorphan hydrobromide (substance) Inferred relationship Some
Product containing precisely dextromethorphan hydrobromide 7.5 milligram and paracetamol 500 milligram and promethazine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextromethorphan hydrobromide (substance) Inferred relationship Some 2
Product containing precisely dextromethorphan hydrobromide 7.5 milligram and paracetamol 500 milligram and promethazine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextromethorphan hydrobromide (substance) Inferred relationship Some 2
Product containing precisely dextromethorphan hydrobromide 750 microgram/1 milliliter and paracetamol 50 milligram/1 milliliter and promethazine hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextromethorphan hydrobromide (substance) Inferred relationship Some 2
Product containing precisely dextromethorphan hydrobromide 750 microgram/1 milliliter and paracetamol 50 milligram/1 milliliter and promethazine hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextromethorphan hydrobromide (substance) Inferred relationship Some 2
Product containing precisely dextromethorphan hydrobromide 1.3 milligram/1 milliliter and diphenhydramine hydrochloride 2.8 milligram/1 milliliter and levomenthol 400 microgram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dextromethorphan hydrobromide (substance) Inferred relationship Some 2
Product containing precisely dextromethorphan hydrobromide 1.3 milligram/1 milliliter and diphenhydramine hydrochloride 2.8 milligram/1 milliliter and levomenthol 400 microgram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dextromethorphan hydrobromide (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start